UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018852
Receipt number R000021806
Scientific Title Efficacy and safety of Antithrombin III administration for the patients with blood coagulation disorder after hepatectomy.
Date of disclosure of the study information 2015/09/20
Last modified on 2020/02/09 16:47:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy and safety of Antithrombin III administration for the patients with blood coagulation disorder after hepatectomy.

Acronym

Efficacy and safety of Antithrombin III administration for the patients with blood coagulation disorder after hepatectomy.

Scientific Title

Efficacy and safety of Antithrombin III administration for the patients with blood coagulation disorder after hepatectomy.

Scientific Title:Acronym

Efficacy and safety of Antithrombin III administration for the patients with blood coagulation disorder after hepatectomy.

Region

Japan


Condition

Condition

Blood coagulation disorder after hepatectomy

Classification by specialty

Surgery in general Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Compare the efficacy and safety of Antithrombin III administration for the patients with blood coagulation disorder after hepatectomy.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Efficacy (Posthepatectomy Liver Failure)

Key secondary outcomes

Safety, Morbidity rate, Mortality rate, Liver function test, Blood coagulation ability


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

A: Administration of gabexate mesilate 1,500mg per day for 4 days after surgery.

Interventions/Control_2

B: Administration of gabexate mesilate 1,500mg per day for 4 days after surgery, and of antithrombin III 1,500mg for 2 days after surgery.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Hepatectomy for hepatic disease
2. Japanese Association for Acute Medicine-defined DIC criteria score > 4 on the day 1st after hepatectomy
3. Written informed consent
4. > = 20 years of age

Key exclusion criteria

1. Clinically significant allergy
2. Clinically significant postoperative liver failure (T.Bil >=5.0mg/dL)
3. Clinically significant postoperative complication
4. Significant lack of antithrombin III (<30%)
5. Splenectomy
6. Presence of anastomosis of alimentary or biliary truct
7. Presence of biliary drainage
8. Clinically significant coagulopathy, renal disfunction or infection
9. Presence of psychological disorder

Target sample size

140


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ohdan Hideki

Organization

Hiroshima University Hospital

Division name

Gasroenterological Surgery

Zip code


Address

1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, JAPAN

TEL

082-257-5222

Email

jimukyoku@hisco-jpn.com


Public contact

Name of contact person

1st name
Middle name
Last name Kobayashi Tsuyoshi

Organization

Hiroshima University Hospital

Division name

Gasroenterological Surgery

Zip code


Address

1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, JAPAN

TEL

082-257-5222

Homepage URL

http://www.hisco-jpn.com/index.html

Email

tsukoba@hiroshima-u.ac.jp


Sponsor or person

Institute

Gasroenterological Surgery, Hiroshima University Hospital

Institute

Department

Personal name



Funding Source

Organization

Hiroshima University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

安佐市民病院(広島県)、尾道総合病院(広島県)、広島総合病院(広島県)、県立広島病院(広島県)、広島大学病院(広島県)、中国労災病院(広島県)、東広島医療センター(広島県)、広島鉄道病院(広島県)、呉医療センター・中国がんセンター(広島県)、吉島病院(広島県)、呉市医師会病院(広島県)


Other administrative information

Date of disclosure of the study information

2015 Year 09 Month 20 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 08 Month 25 Day

Date of IRB

2015 Year 08 Month 10 Day

Anticipated trial start date

2015 Year 10 Month 01 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry

2019 Year 03 Month 31 Day

Date trial data considered complete

2019 Year 03 Month 31 Day

Date analysis concluded

2019 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2015 Year 08 Month 30 Day

Last modified on

2020 Year 02 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021806


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name